Patients after breast cancer treatment were divided into subgroups according to the following characteristics: the presence of vestibulo-atactic syndrome, depression, polyneuropathy, lymphedema, breast cancer hormone-receptor status, as well as anamnesis of radiation therapy and chemotherapy. This evidence concerns the gene NR4A1 and depressive disorder.